PPARG and Other metabolic disease: Polyunsaturated fatty acids (PUFAs) are known to function as agonists of PPAR-γ, a nuclear receptor that has been getting increasing interest as a novel therapeutic target for the treatment of diabetes and related metabolic disorders [35].